Biotech · Private company
InnoCare Pharma Inc.
Track this companyFree. Adds InnoCare Pharma Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- ICP-248Phase 1 · Mature B-cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- ICP-332 TabletsPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- ICP-723Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- Obinutuzumab (G)Phase 1 · Mature B-cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
- Rituximab (R)Phase 1 · Mature B-cell MalignanciesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase I Study of ICP-332 in Healthy SubjectsPHASE1 · COMPLETED · started Jul 23, 2024ClinicalTrials.gov NCT06530966 · fetched Nov 12, 2026
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell MalignanciesPHASE1 · RECRUITING · started Apr 23, 2024ClinicalTrials.gov NCT06351527 · fetched Nov 12, 2026
- Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-723 in Patients With Advanced Solid TumorsPHASE1 · UNKNOWN · started Jul 30, 2021ClinicalTrials.gov NCT05537987 · fetched Nov 12, 2026